C.M. Bidwell & Associates’s Veracyte VCYT Stock Holding History
Bought
Maintained
Sold
Other funds holding VCYT
AIM
C.M. Bidwell & Associates's VCYT Position: Q2 2026 in Review
C.M. Bidwell & Associates held its Veracyte (VCYT) position steady in Q2 2026 at 118 shares worth $6.93K. The position accounts for ﹤0.01% of the portfolio, ranked #309.
C.M. Bidwell & Associates first reported a position in VCYT in Q1 2019 and has held it in 22 quarters since. The position peaked at $101K in Q1 2019. 370 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.
- C.M. Bidwell & Associates held 118 shares of Veracyte worth $6.93K as of Q2 2026.
- C.M. Bidwell & Associates left its Veracyte share count unchanged in Q2 2026.
- Veracyte made up ﹤0.01% of C.M. Bidwell & Associates's portfolio in Q2 2026, its #309 holding.
- C.M. Bidwell & Associates first reported a position in Veracyte in Q1 2019 and has held it in 22 quarters since.
- C.M. Bidwell & Associates's Veracyte position peaked at $101K in Q1 2019.
- 370 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.
Based on C.M. Bidwell & Associates's 13F filing for Q2 2026, filed 11 Aug 2026.